In terms of Regulation 30 of the SEBI Listing Regulations, Biofil Chemicals and Pharmaceuticals has informed that it enclosed information to be disseminated on the website of the Company regarding KYC details and Nomination in terms of SEBI Circular No. SEBI/HO/MIRSD/MIRSD-PoD-1/P/CIR/2023/37 dated March 16, 2023 (the ‘SEBI Circular’). Further, in terms of the SEBI Circular, the said information shall also be intimated directly to the concerned securities holders in due course.
The above information is a part of company’s filings submitted to BSE.
